康拓医疗: 西安康拓医疗技术股份有限公司2025年半年度报告摘要

Core Viewpoint - Xi'an Kontuo Medical Technology Co., Ltd. reported a positive financial performance for the first half of 2025, with significant increases in revenue and net profit, alongside a planned cash dividend distribution to shareholders [1]. Financial Performance - Total assets as of the end of the reporting period amounted to ¥778,070,632.43, reflecting a 4.13% increase from the previous year [3]. - The net assets attributable to shareholders reached ¥680,693,200.44, up 7.10% compared to the previous year [3]. - Operating revenue for the period was ¥170,316,349.76, representing an 11.07% increase year-on-year [3]. - Total profit for the period was ¥65,359,324.72, which is a 10.27% increase from the previous year [3]. - Net profit attributable to shareholders was ¥54,998,635.19, marking a 12.72% increase compared to the same period last year [3]. - The basic earnings per share were ¥0.68, up 13.33% from ¥0.60 in the previous year [3]. Dividend Distribution - The company plans to distribute a cash dividend of ¥2 per 10 shares (including tax) to all shareholders, amounting to a total of ¥16,247,834.40 based on the total share capital of 81,239,172 shares [1].